Together, these data indicate a key role for MED1 overexpression in promoting MMTV-HER2 tumor onset and growth, and demonstrate the clinical relevance of our newly established MMTV-HER2/MMTV-MED1 mammary tumor model. This evidence concerns the gene MED1 and breast cancer.